Chargement en cours...
M2HepPrEP: study protocol for a multi-site multi-setting randomized controlled trial of integrated HIV prevention and HCV care for PWID
Abstract Background Opioid use is escalating in North America and comes with a multitude of health consequences, including HIV and hepatitis C virus (HCV) outbreaks among persons who inject drugs (PWID). HIV pre-exposure prophylaxis (PrEP) and HCV treatment regimens have transformative potential to...
Enregistré dans:
Auteurs principaux: | , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Artigo |
Langue: | Inglês |
Publié: |
BMC
2022-04-01
|
Collection: | Trials |
Sujets: | |
Accès en ligne: | https://doi.org/10.1186/s13063-022-06085-3 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|